RRD was founded in 2002 on a basic premise: Create an alternative approach to drug development that enables more efficient use of capital and accelerates an asset's value inflection point. Our Product Development Team (PDT) partnering model anticipated the shift in early drug development from large pharma to biotech and has a long track record of value creation.